The DOI matches its Crossref record; 91 of the 91 references it cites were found in a registry or an index.
Genetics of acquired long QT syndrome
Open accessAbstract
The QT interval is the electrocardiographic manifestation of ventricular repolarization, is variable under physiologic conditions, and is measurably prolonged by many drugs. Rarely, however, individuals with normal base-line intervals may display exaggerated QT interval prolongation, and the potentially fatal polymorphic ventricular tachycardia torsade de pointes, with drugs or other environmental stressors such as heart block or heart failure. This review summarizes the molecular and cellular mechanisms underlying this acquired or drug-induced form of long QT syndrome, describes approaches to the analysis of a role for DNA variants in the mediation of individual susceptibility, and proposes that these concepts may be generalizable to common acquired arrhythmias.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The International HapMap Project
†The International HapMap Consortium, Genotyping centres: Baylor College of Medicine and ParAllele BioScience, Gibbs, R. A., Belmont, J. W., Hardenbol, P., Willis, T. D., Yu, F., Chinese HapMap Consortium, Yang, H., Ch'ang, L.-Y., et al. (2003) · Nature · doi:10.1038/nature02168 · Cited by 6,057
The Cardiac Arrhythmia Suppression Trial (CAST) Investigators (1989) · New England Journal of Medicine · doi:10.1056/nejm198908103210629 · Cited by 3,300
Sanguinetti, M. C., Jiang, C., Curran, M. E., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90340-2 · Cited by 2,423
A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome
Curran, M. E., Splawski, I., Timothy, K. W., Vincen, G. M., Green, E. D., & Keating, M. T. (1995) · Cell · doi:10.1016/0092-8674(95)90358-5 · Cited by 2,259
Drug-induced prolongation of the QT interval
Roden, D. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmra032426 · Cited by 1,965
Self-citationReplication validity of genetic association studies
Ioannidis, J. P. A., Ntzani, E. E., Trikalinos, T. A., & Contopoulos-Ioannidis, D. G. (2001) · Nature Genetics · doi:10.1038/ng749 · Cited by 1,832
Antzelevitch, C., Brugada, P., Borggrefe, M., Brugada, J., Brugada, R., Corrado, D., Gussak, I., LeMarec, H., Nademanee, K., Perez Riera, A. R., et al. (2005) · Circulation · doi:10.1161/01.cir.0000152479.54298.51 · Cited by 1,807
A comprehensive review of genetic association studies
Hirschhorn, J. N., Lohmueller, K., Byrne, E., & Hirschhorn, K. (2002) · Genetics in Medicine · doi:10.1097/00125817-200203000-00002 · Cited by 1,674
Luo, C. H., & Rudy, Y. (1991) · Circulation Research · doi:10.1161/01.res.68.6.1501 · Cited by 1,468
MiRP1 Forms IKr Potassium Channels with HERG and Is Associated with Cardiac Arrhythmia
Abbott, G. W., Sesti, F., Splawski, I., Buck, M. E., Lehmann, M. H., Timothy, K. W., Keating, M. T., & Goldstein, S. A. N. (1999) · Cell · doi:10.1016/s0092-8674(00)80728-x · Cited by 1,354
Yan, G.-X., & Antzelevitch, C. (1999) · Circulation · doi:10.1161/01.cir.100.15.1660 · Cited by 1,126
Dofetilide in Patients with Congestive Heart Failure and Left Ventricular Dysfunction
Torp-Pedersen, C., Møller, M., Bloch-Thomsen, P. E., Køber, L., Sandøe, E., Egstrup, K., Agner, E., Carlsen, J., Videbæk, J., Marchant, B., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199909163411201 · Cited by 1,012
Yan, G.-X., & Antzelevitch, C. (1998) · Circulation · doi:10.1161/01.cir.98.18.1928 · Cited by 988
Female Gender as a Risk Factor for Torsades de Pointes Associated With Cardiovascular Drugs
Makkar, R. R. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03510210076031 · Cited by 971
A structural basis for drug-induced long QT syndrome
Mitcheson, J. S., Chen, J., Lin, M., Culberson, C., & Sanguinetti, M. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.210244497 · Cited by 944
The long QT syndromes: A critical review, new clinical observations and a unifying hypothesis
Jackman, W. M., Friday, K. J., Anderson, J. L., Aliot, E. M., Clark, M., & Lazzara, R. (1988) · Progress in Cardiovascular Diseases · doi:10.1016/0033-0620(88)90014-x · Cited by 783
QT dispersion and sudden unexpected death in chronic heart failure
Barr, C. S., Naas, A., Freeman, M., Lang, C. C., & Struthers, A. D. (1994) · The Lancet · doi:10.1016/s0140-6736(94)91164-9 · Cited by 769
QT interval prolongation as predictor of sudden death in patients with myocardial infarction.
Schwartz, P. J., & Wolf, S. (1978) · Circulation · doi:10.1161/01.cir.57.6.1074 · Cited by 753
Electrophysiological Effects of Ranolazine, a Novel Antianginal Agent With Antiarrhythmic Properties
Antzelevitch, C., Belardinelli, L., Zygmunt, A. C., Burashnikov, A., Di Diego, J. M., Fish, J. M., Cordeiro, J. M., & Thomas, G. (2004) · Circulation · doi:10.1161/01.cir.0000139333.83620.5d · Cited by 675
Taking the “Idio” out of “Idiosyncratic”: Predicting Torsades de Pointes
RODEN, D. M. (1998) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.1998.tb00148.x · Cited by 667
Self-citationMechanism of the Cardiotoxic Actions of Terfenadine
Woosley, R. L. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500120070028 · Cited by 646
Predicting Sudden Death in the Population: The Paris Prospective Study I
Jouven, X., Desnos, M., Guerot, C., & Ducimetière, P. (1999) · Circulation · doi:10.1161/01.cir.99.15.1978 · Cited by 644
Treatment of torsade de pointes with magnesium sulfate.
Tzivoni, D., Banai, S., Schuger, C., Benhorin, J., Keren, A., Gottlieb, S., & Stern, S. (1988) · Circulation · doi:10.1161/01.cir.77.2.392 · Cited by 614
Brugada Syndrome: Report of the Second Consensus Conference
(2005) · Heart Rhythm · doi:10.1016/j.hrthm.2005.01.005 · Cited by 609
Liu, D.-W., & Antzelevitch, C. (1995) · Circulation Research · doi:10.1161/01.res.76.3.351 · Cited by 609
Parental atrial fibrillation as a risk factor for atrial fibrillation in offspring
Fox, C. S. (2004) · JAMA · doi:10.1001/jama.291.23.2851 · Cited by 600
Allelic Variants in Long-QT Disease Genes in Patients With Drug-Associated Torsades de Pointes
Yang, P., Kanki, H., Drolet, B., Yang, T., Wei, J., Viswanathan, P. C., Hohnloser, S. H., Shimizu, W., Schwartz, P. J., Stanton, M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000014448.19052.4c · Cited by 554
Self-citationVariant of SCN5A Sodium Channel Implicated in Risk of Cardiac Arrhythmia
Splawski, I., Timothy, K. W., Tateyama, M., Clancy, C. E., Malhotra, A., Beggs, A. H., Cappuccio, F. P., Sagnella, G. A., Kass, R. S., & Keating, M. T. (2002) · Science · doi:10.1126/science.1073569 · Cited by 523
Oral Erythromycin and the Risk of Sudden Death from Cardiac Causes
Ray, W. A., Murray, K. T., Meredith, S., Narasimhulu, S. S., Hall, K., & Stein, C. M. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040582 · Cited by 496
Roden, D. M., Woosley, R. L., & Primm, R. K. (1986) · American Heart Journal · doi:10.1016/0002-8703(86)90010-4 · Cited by 488
Self-citationHaverkamp*, W. (2000) · Cardiovascular Research · doi:10.1016/s0008-6363(00)00119-x · Cited by 486
A common polymorphism associated with antibiotic-induced cardiac arrhythmia
Sesti, F., Abbott, G. W., Wei, J., Murray, K. T., Saksena, S., Schwartz, P. J., Priori, S. G., Roden, D. M., George, A. L., & Goldstein, S. A. N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180223197 · Cited by 479
Self-citationNeal Kay, G., Vance J., P., Joaquin G., A., Richard W., H., & Albert L., W. (1983) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(83)80226-5 · Cited by 463
Yang, T., & Roden, D. M. (1996) · Circulation · doi:10.1161/01.cir.93.3.407 · Cited by 429
Self-citationSudden cardiac death in heart failure. The role of abnormal repolarization.
Tomaselli, G. F., Beuckelmann, D. J., Calkins, H. G., Berger, R. D., Kessler, P. D., Lawrence, J. H., Kass, D., Feldman, A. M., & Marban, E. (1994) · Circulation · doi:10.1161/01.cir.90.5.2534 · Cited by 418
[Ventricular tachycardia with 2 variable opposing foci].
Dessertenne, F. (1966) · PubMed · Cited by 414
Haverkamp, W. (2000) · European Heart Journal · doi:10.1053/euhj.2000.2249 · Cited by 414
Ionic Current Basis of Electrocardiographic Waveforms: A Model Study
Gima, K., & Rudy, Y. (2002) · Circulation Research · doi:10.1161/01.res.0000016960.61087.86 · Cited by 396
Shimizu, W., & Antzelevitch, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00582-3 · Cited by 378
Thomsen, M. B., Verduyn, S. C., Stengl, M., Beekman, J. D. M., de Pater, G., van Opstal, J., Volders, P. G. A., & Vos, M. A. (2004) · Circulation · doi:10.1161/01.cir.0000145162.64183.c8 · Cited by 361
Viswanathan, P. C., Shaw, R. M., & Rudy, Y. (1999) · Circulation · doi:10.1161/01.cir.99.18.2466 · Cited by 357
KVLQT1 C-Terminal Missense Mutation Causes a Forme Fruste Long-QT Syndrome
Donger, C., Denjoy, I., Berthet, M., Neyroud, N., Cruaud, C., Bennaceur, M., Chivoret, G., Schwartz, K., Coumel, P., & Guicheney, P. (1997) · Circulation · doi:10.1161/01.cir.96.9.2778 · Cited by 348
Drug‐Induced Torsades de Pointes and Implications for Drug Development
FENICHEL, R. R., MALIK, M., ANTZELEVITCH, C., SANGUINETTI, M., RODEN, D. M., PRIORI, S. G., RUSKIN, J. N., LIPICKY, R. J., CANTILENA, L. R., & Independent Academic Task Force (2004) · Journal of Cardiovascular Electrophysiology · doi:10.1046/j.1540-8167.2004.03534.x · Cited by 346
Self-citationRoden, D. M., & Hoffman, B. F. (1985) · Circulation Research · doi:10.1161/01.res.56.6.857 · Cited by 340
Self-citationKøber, L., Thomsen, P. E. B., Møller, M., Torp-Pedersen, C., Carlsen, J., Sandøe, E., Egstrup, K., Agner, E., Videbæk, J., Marchant, B., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03402-4 · Cited by 338
Family History as a Risk Factor for Primary Cardiac Arrest
Friedlander, Y., Siscovick, D. S., Weinmann, S., Austin, M. A., Psaty, B. M., Lemaitre, R. N., Arbogast, P., Raghunathan, T. E., & Cobb, L. A. (1998) · Circulation · doi:10.1161/01.cir.97.2.155 · Cited by 336
Cisapride and Fatal Arrhythmia
Wysowski, D. K., & Bacsanyi, J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607253350416 · Cited by 331
Familial atrial fibrillation is a genetically heterogeneous disorder
Darbar, D., Herron, K. J., Ballew, J. D., Jahangir, A., Gersh, B. J., Shen, W.-K., Hammill, S. C., Packer, D. L., & Olson, T. M. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(03)00465-0 · Cited by 330
Brachmann, J., Scherlag, B. J., Rosenshtraukh, L. V., & Lazzara, R. (1983) · Circulation · doi:10.1161/01.cir.68.4.846 · Cited by 312
Akar, F. G., Yan, G.-X., Antzelevitch, C., & Rosenbaum, D. S. (2002) · Circulation · doi:10.1161/hc1002.105231 · Cited by 302
Assessing predictors of drug-induced torsade de pointes
Belardinelli, L., Antzelevitch, C., & Vos, M. A. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.10.002 · Cited by 302
NAPOLITANO, C., SCHWARTZ, P. J., BROWN, A. M., RONCHETTI, E., BIANCHI, L., PINNAVAIA, A., ACQUARO, G., & PRIORI, S. G. (2000) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2000.tb00033.x · Cited by 300
Prolonged QT interval predicts cardiac and all-cause mortality in the elderly The Rotterdam Study
de Bruyne, M. (1999) · European Heart Journal · doi:10.1053/euhj.1998.1276 · Cited by 298
Ackerman, M. J., Tester, D. J., Jones, G. S., Will, M. L., Burrow, C. R., & Curran, M. E. (2003) · Mayo Clinic Proceedings · doi:10.4065/78.12.1479 · Cited by 297
Long QT syndrome: from channels to cardiac arrhythmias
Moss, A. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25537 · Cited by 296
Rampe, D., Roy, M.-L., Dennis, A., & Brown, A. M. (1997) · FEBS Letters · doi:10.1016/s0014-5793(97)01249-0 · Cited by 293
Transmural Electrophysiological Heterogeneities Underlying Arrhythmogenesis in Heart Failure
Akar, F. G., & Rosenbaum, D. S. (2003) · Circulation Research · doi:10.1161/01.res.0000092248.59479.ae · Cited by 291
Paulussen, A. D. C., Gilissen, R. A. H. J., Armstrong, M., Doevendans, P. A., Verhasselt, P., Smeets, H. J. M., Schulze-Bahr, E., Haverkamp, W., Breithardt, G., Cohen, N., et al. (2004) · Journal of Molecular Medicine · doi:10.1007/s00109-003-0522-z · Cited by 280
Evaluation of Drug-Induced QT Interval Prolongation: Implications for Drug Approval and Labelling
Malik, M., & Camm, A. J. (2001) · Drug Safety · doi:10.2165/00002018-200124050-00001 · Cited by 273
Torsade de Pointes Due to Noncardiac Drugs: Most Patients Have Easily Identifiable Risk Factors
Zeltser, D., Justo, D., Halkin, A., Prokhorov, V., Heller, K., & Viskin, S. (2003) · Medicine · doi:10.1097/01.md.0000085057.63483.9b · Cited by 273
Physicochemical Features of the hERG Channel Drug Binding Site
Fernandez, D., Ghanta, A., Kauffman, G. W., & Sanguinetti, M. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310683200 · Cited by 266
Wang, S., Liu, S., Morales, M. J., Strauss, H. C., & Rasmusson, R. L. (1997) · The Journal of Physiology · doi:10.1111/j.1469-7793.1997.045bl.x · Cited by 254
Zygmunt, A. C., Eddlestone, G. T., Thomas, G. P., Nesterenko, V. V., & Antzelevitch, C. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.2.h689 · Cited by 254
Electrophysiological and Beta-Receptor Blocking Effects of MJ 1999 on Dog and Rabbit Cardiac Tissue
STRAUSS, H. C., BIGGER, J. T., & HOFFMAN, B. F. (1970) · Circulation Research · doi:10.1161/01.res.26.6.661 · Cited by 241
Carlsson, L., Almgren, O., & Duker, G. (1990) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199008000-00014 · Cited by 235
Carlsson, L., Abrahamsson, C., Andersson, B., Duker, G., & Schiller-Linhardt, G. (1993) · Cardiovascular Research · doi:10.1093/cvr/27.12.2186 · Cited by 213
Extramiana, F., & Antzelevitch, C. (2004) · Circulation · doi:10.1161/01.cir.0000143078.48699.0c · Cited by 211
Normalization of Acquired QT Prolongation in Humans by Intravenous Potassium
Choy, A. M., Lang, C. C., Chomsky, D. M., Rayos, G. H., Wilson, J. R., & Roden, D. M. (1997) · Circulation · doi:10.1161/01.cir.96.7.2149 · Cited by 196
Self-citationPause induced early afterdepolarizations in the long QT syndrome: a simulation study
Viswanathan, P. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00035-8 · Cited by 190
Volders, P. G. A., Sipido, K. R., Vos, M. A., Kulcsár, A., Verduyn, S. C., & Wellens, H. J. J. (1998) · Circulation · doi:10.1161/01.cir.98.11.1136 · Cited by 183
Yang, T., Snyders, D. J., & Roden, D. M. (1997) · Circulation Research · doi:10.1161/01.res.80.6.782 · Cited by 172
Self-citationShimizu, W., Ohe, T., Kurita, T., Kawade, M., Arakaki, Y., Aihara, N., Kamakura, S., Kamiya, T., & Shimomura, K. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00313-4 · Cited by 164
Locati, E. H., Maison-Blanche, P., Dejode, P., Cauchemez, B., & Coumel, P. (1995) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(95)00100-i · Cited by 144
Long QT syndrome caused by noncardiac drugs
Viskin, S., Justo, D., Halkin, A., & Zeltser, D. (2003) · Progress in Cardiovascular Diseases · doi:10.1053/pcad.2003.00101 · Cited by 142
Anderson, M. E., Al‐Khatib, S. M., Roden, D. M., & Califf, R. M. (2002) · American Heart Journal · doi:10.1067/mhj.2002.125804 · Cited by 136
Self-citationSudden Cardiac Death in Heart Failure
Marbán, E., & Tomaselli, G. F. (1998) · Medical science symposia series · doi:10.1007/978-94-011-5022-4_40 · Cited by 130
Nattel, S., & Quantz, M. (1988) · Cardiovascular Research · doi:10.1093/cvr/22.11.808 · Cited by 127
Acceleration‐Induced Action Potential Prolongation and Early Afterdepolarizations
Burashnikov, A., & Antzelevitch, C. N. (1998) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1998.tb00134.x · Cited by 125
Anderson, M. E., Al‐Khatib, S. M., Roden, D. M., & Califf, R. M. (2002) · American Heart Journal · doi:10.1016/s0002-8703(02)80007-2 · Cited by 124
Self-citationSánchez‐Chapula, J. A., Ferrer, T., Navarro‐Polanco, R. A., & Sanguinetti, M. C. (2003) · Molecular Pharmacology · doi:10.1124/mol.63.5.1051 · Cited by 119
Arrhythmogenic mechanisms of QT prolonging drugs: Is QT prolongation really the problem?
Antzelevitch, C. N. (2004) · Journal of Electrocardiology · doi:10.1016/j.jelectrocard.2004.08.004 · Cited by 110
Calmodulin Kinase Inhibition Prevents Development of the Arrhythmogenic Transient Inward Current
Wu, Y., Roden, D. M., & Anderson, M. E. (1999) · Circulation Research · doi:10.1161/01.res.84.8.906 · Cited by 110
Self-citationNattel, S., Ranger, S., Talajic, M. R., Lemery, R., & Roy, D. (1990) · The American Journal of Medicine · doi:10.1016/0002-9343(90)90305-w · Cited by 104
Role of Na+:Ca2+ Exchange Current in Cs+‐Induced Early Afterdepolarizations in Purkinje Fibers
Szabó, B., Sweidan, R., RAJAGOPALAN, C. V., & Lazzara, R. (1994) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.1994.tb01133.x · Cited by 93
Amiodarone and Torsade de Pointes
Lazzara, R. (1989) · Annals of Internal Medicine · doi:10.7326/0003-4819-111-7-549 · Cited by 93
Pause-dependent torsade de pointes following acute myocardial infarction
Halkin, A., Roth, A., Lurie, I., Fish, R., Belhassen, B., & Viskin, S. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01468-1 · Cited by 92
Exaggerated QT prolongation after cardioversion of atrial fibrillation
Choy, A. M. J., Darbar, D., Dell’Orto, S., & Roden, D. M. (1999) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(99)00226-0 · Cited by 89
Self-citationAntiarrhythmic Drug Target Choices and Screening
Sanguinetti, M. C., & Bennett, P. B. (2003) · Circulation Research · doi:10.1161/01.res.0000091829.63501.a8 · Cited by 68
Petersen, C. I., McFarland, T. R., Stepanovic, S. Z., Yang, P., Reiner, D. J., Hayashi, K., George, A. L., Roden, D. M., Thomas, J. H., & Balser, J. R. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0306005101 · Cited by 53
Self-citationAmiodarone and torsades de pointes
Jorens, P. G., van den Heuvel, P. A., & Parizel, G. A. (1990) · American Heart Journal · doi:10.1016/0002-8703(90)90276-4 · Cited by 15
Proarrhythmic effects of a quinidine analog in dogs with chronic A‐V block
Chézalviel, F., WEISSENBURGER, J., Davy, J., Guhennec, C., Poirier, J., & CHEYMOL, G. (1995) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.1995.tb00291.x · Cited by 14
Cited by
Drew, B. J., Ackerman, M. J., Funk, M., Gibler, W. B., Kligfield, P., Menon, V., Philippides, G. J., Roden, D. M., & Zareba, W. (2010) · Circulation · doi:10.1161/circulationaha.109.192704 · Cited by 821
Self-citationUsing induced pluripotent stem cells to investigate cardiac phenotypes in Timothy syndrome
Yazawa, M., Hsueh, B., Jia, X., Pasca, A. M., Bernstein, J. A., Hallmayer, J., & Dolmetsch, R. E. (2011) · Nature · doi:10.1038/nature09855 · Cited by 677
Kannankeril, P., Roden, D. M., & Darbar, D. (2010) · Pharmacological Reviews · doi:10.1124/pr.110.003723 · Cited by 440
Self-citationThe genetic basis of long QT and short QT syndromes: A mutation update
Hedley, P. L., Jørgensen, P., Schlamowitz, S., Wangari, R., Moolman-Smook, J., Brink, P. A., Kanters, J. K., Corfield, V. A., & Christiansen, M. (2009) · Human Mutation · doi:10.1002/humu.21106 · Cited by 429
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Wilke, R. A., Lin, D. W., Roden, D. M., Watkins, P. B., Flockhart, D., Zineh, I., Giacomini, K. M., & Krauss, R. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2423 · Cited by 391
Self-citation
Metadata
- Authors
- Roden, D. M.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-08-01
- Volume
- 115
- Issue
- 8
- Pages
- 2025-2032
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2057406399
- Cited by
- 256
- References
- 91
- FWCI
- 12.94
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.